Clearance Summary
OGmend® Implant Enhancement System received FDA 510(k) clearance under submission number K233223, sponsored by Woven Orthopedic Technologies. The device was reviewed via the Special premarket notification pathway and assigned to the Orthopedic review panel. The statutory decision date of record is 2023-10-26.
- Submission: K233223
- Applicant / Sponsor: Woven Orthopedic Technologies
- Clearance pathway: Special
- Review panel: Orthopedic
- Device class: Class II
- Regulation citation: 21 CFR 888.3043
- Decision date: 2023-10-26
Classification & Regulation
This clearance is catalogued under FDA product code QVI and 21 CFR 888.3043, within the Orthopedic review panel as a Class II device.